David Floyd

Senior Adviser

David Floyd is part of Permira’s Value Creation Team, where he leads the application of AI and advanced analytics to drive impact across the Healthcare portfolio. He works strategically with companies including Neuraxpharm, Quotient Sciences, Cambrex, and Valeris, and has been involved in recent transactions such as Clearwater, PharmaCord, and Mercalis.

While healthcare is now his primary focus, David brings deep cross-sector expertise, having driven data-led transformation in Consumer, Technology, Industrial and Services businesses.

Before joining Permira, David was a Partner at Leap Beyond, a specialist AI and analytics consultancy, where he led the Data Science team and founded the London office. Over the past 12 years, he has applied AI techniques—including computer vision, natural language processing, and machine learning—in highly regulated environments spanning life sciences, finance, government, and consumer sectors.

Earlier in his career, David spent a decade in academic astrophysics, working with large-scale scientific data at world-leading institutions including NASA’s Space Telescope Science Institute.

Qualifications

David holds a PhD in Astronomy and a degree in Astrophysics from the University of Edinburgh. With over 20 years of experience at the intersection of data, science, and strategy, he brings a unique blend of technical depth and commercial impact.